This report aims to describe the study visit of researchers at Christian Medical College (CMC) Vellore who are undertaking cost of illness studies on enteric fever and rotavirus vaccines in India at the Health Intervention and Technology Assessment Program (HITAP). HITAP, known regionally for suppor

This course was organised at the request of Prof. Rakesh Aggarwal, the Director of JIPMER and Prof. Gagandeep Kang, the Executive Director of THSTI and Professor at the Christian Medical College (CMC) in Vellore, India. The main objective of the course was to build technical capacity of stakeholders

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8* † Contributed equally 8

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics. Roma´n Pe´ rez Velasco1*, Naiyana Praditsitthikorn1, Kamonthip Wichmann1, Adun Mohara1, Surachai Kotirum1, Sripen Tantivess1, Constanza Vallenas2, Hande Harmanci2, Yot Teerawattanan

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,

Full text can be accessed from: http://www.sciencedirect.com/science/article/pii/S0264410X14017058

Benjarin Santatiwongchai1, Varit Chantarastapornchit1*, Thomas Wilkinson2, Kittiphong Thiboonboon1, Waranya Rattanavipapong1, Damian G Walker3, Kalipso Chalkidou2, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Nonthaburi, Thailand, 2 NICE International,National Insti

Manuel Alexander Haasis1*, Joyce Anne Ceria1, Wantanee Kulpeng2, Yot Teerawattananon2, Marissa Alejandria3 1 National Center for Pharmaceutical Access and Management (NCPAM), Department of Health, Manila, Philippines, 2 Health Intervention and Technology Assessment Program (HITAP), Department of